The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.
The global Influenza Vaccine market was valued at US$ 5154 million in 2020 and is expected to reach US$ 6867 million by the end of 2027, growing at a CAGR of 3.8% during 2021-2027.
This report focuses on Influenza Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Influenza Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Influenza Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
CSL
GSK
Sanofi Pasteur
Mylan
Hulan Bio
AstraZeneca
CCBIO
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.
The global Influenza Vaccine market was valued at US$ 5154 million in 2020 and is expected to reach US$ 6867 million by the end of 2027, growing at a CAGR of 3.8% during 2021-2027.
This report focuses on Influenza Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Influenza Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Influenza Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
CSL
GSK
Sanofi Pasteur
Mylan
Hulan Bio
AstraZeneca
CCBIO
Index1 Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Influenza Vaccine
1.2 Influenza Vaccine Segment by Type
1.2.1 Global Influenza Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Influenza Vaccine Segment by Application
1.3.1 Global Influenza Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Influenza Vaccine Revenue 2016-2027
1.4.2 Global Influenza Vaccine Sales 2016-2027
1.4.3 Influenza Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Influenza Vaccine Market Competition by Manufacturers
2.1 Global Influenza Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Influenza Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Influenza Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Influenza Vaccine Players Market Share by Revenue
2.5.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Influenza Vaccine Sales by Country
3.3.2 North America Influenza Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Influenza Vaccine Sales by Country
3.4.2 Europe Influenza Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Influenza Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Influenza Vaccine Sales by Country
3.6.2 Latin America Influenza Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Influenza Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Influenza Vaccine Historic Market Analysis by Type
4.1 Global Influenza Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Influenza Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Influenza Vaccine Price by Type (2016-2021)
5 Global Influenza Vaccine Historic Market Analysis by Application
5.1 Global Influenza Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Influenza Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Influenza Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Influenza Vaccine Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Influenza Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Pasteur Influenza Vaccine Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Influenza Vaccine Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hulan Bio Influenza Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 AstraZeneca Influenza Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description and Business Overview
6.6.3 CCBIO Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CCBIO Influenza Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments/Updates
7 Influenza Vaccine Manufacturing Cost Analysis
7.1 Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Influenza Vaccine
7.4 Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Influenza Vaccine Distributors List
8.3 Influenza Vaccine Customers
9 Influenza Vaccine Market Dynamics
9.1 Influenza Vaccine Industry Trends
9.2 Influenza Vaccine Growth Drivers
9.3 Influenza Vaccine Market Challenges
9.4 Influenza Vaccine Market Restraints
10 Global Market Forecast
10.1 Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Influenza Vaccine by Type (2022-2027)
10.2 Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Influenza Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Influenza Vaccine by Application (2022-2027)
10.3 Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Influenza Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Influenza Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Influenza Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Influenza Vaccine Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Influenza Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Influenza Vaccine Covered in This Study
Table 5. Global Influenza Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Influenza Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Influenza Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Influenza Vaccine Average Price (USD/Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Influenza Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Influenza Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Influenza Vaccine Sales by Region (2016-2021) & (M Doses)
Table 16. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 19. North America Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Influenza Vaccine Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Influenza Vaccine Sales (M Doses) by Type (2016-2021)
Table 39. Global Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Influenza Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Influenza Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Influenza Vaccine Price (USD/Doses) by Type (2016-2021)
Table 43. Global Influenza Vaccine Sales (M Doses) by Application (2016-2021)
Table 44. Global Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Influenza Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Influenza Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Influenza Vaccine Price (USD/Doses) by Application (2016-2021)
Table 48. CSL Corporation Information
Table 49. CSL Description and Business Overview
Table 50. CSL Influenza Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 51. CSL Influenza Vaccine Product
Table 52. CSL Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Influenza Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 56. GSK Influenza Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Pasteur Corporation Information
Table 59. Sanofi Pasteur Description and Business Overview
Table 60. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 61. Sanofi Pasteur Influenza Vaccine Product
Table 62. Sanofi Pasteur Recent Developments/Updates
Table 63. Mylan Corporation Information
Table 64. Mylan Description and Business Overview
Table 65. Mylan Influenza Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 66. Mylan Influenza Vaccine Product
Table 67. Mylan Recent Developments/Updates
Table 68. Hulan Bio Corporation Information
Table 69. Hulan Bio Description and Business Overview
Table 70. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 71. Hulan Bio Influenza Vaccine Product
Table 72. Hulan Bio Recent Developments/Updates
Table 73. AstraZeneca Corporation Information
Table 74. AstraZeneca Description and Business Overview
Table 75. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 76. AstraZeneca Influenza Vaccine Product
Table 77. AstraZeneca Recent Developments/Updates
Table 78. CCBIO Corporation Information
Table 79. CCBIO Description and Business Overview
Table 80. CCBIO Influenza Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 81. CCBIO Influenza Vaccine Product
Table 82. CCBIO Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Influenza Vaccine Distributors List
Table 86. Influenza Vaccine Customers List
Table 87. Influenza Vaccine Market Trends
Table 88. Influenza Vaccine Growth Drivers
Table 89. Influenza Vaccine Market Challenges
Table 90. Influenza Vaccine Market Restraints
Table 91. Global Influenza Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 92. Global Influenza Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Influenza Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Influenza Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Influenza Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 96. Global Influenza Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Influenza Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Influenza Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Influenza Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 100. Global Influenza Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Influenza Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Influenza Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Vaccine
Figure 2. Global Influenza Vaccine Market Share by Type in 2020 & 2027
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Influenza Vaccine Market Share by Application in 2020 & 2027
Figure 6. For Children (6 months to 3 years)
Figure 7. For Adults and Children over 3 years
Figure 8. Global Influenza Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Influenza Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Influenza Vaccine Sales 2016-2027 (M Doses)
Figure 11. Global Influenza Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Influenza Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Influenza Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Influenza Vaccine Players: Market Share by Revenue in 2020
Figure 15. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Influenza Vaccine Sales Market Share by Region in 2020
Figure 18. Global Influenza Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Influenza Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Taiwan Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Mexico Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Brazil Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Argentina Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Turkey Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. UAE Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Sales Market Share of Influenza Vaccine by Type (2016-2021)
Figure 43. Sales Market Share of Influenza Vaccine by Application (2016-2021)
Figure 44. Sales Market Share of Influenza Vaccine by Application in 2020
Figure 45. Revenue Share of Influenza Vaccine by Application (2016-2021)
Figure 46. Revenue Share of Influenza Vaccine by Application in 2020
Figure 47. Manufacturing Cost Structure of Influenza Vaccine
Figure 48. Manufacturing Process Analysis of Influenza Vaccine
Figure 49. Influenza Vaccine Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
